OptionsWhile I am incredibly frustrated by the deviation in timing and the size of options granted back in late 2021, I do find solace in the fact thiat this occured. This is perhaps the biggest tell that they have something meaningful in the works. Could be oncology or Nash, but they would not rush that through if there was not a high possibility that they would be releacing materially positive information before the end of March.